Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/544445 stock hub

BOM/544445 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/544445is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

680.5M

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/544445

In the news

Latest news · BOM/544445

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E21.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC11.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/544445 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

INR

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Enterprise value	INR 718.6M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 680.5M
Price	INR 79.94
Price currency	INR
Sic	2834
Symbol	bom/544445
Website	https://www.asstonpharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.61%
EV Earnings	29.24x
EV/EBIT	11.53x
EV/EBITDA	11.3x
EV/Sales	2.94x
P/B ratio	1.76x
P/E ratio	21.25x
P/S ratio	2.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.46%
EBITDA Margin	25.97%
Gross margin	45.88%
Gross Profit	INR 112.3M
Gross Profit Growth	252.27%
Gross Profit Growth Q	5.56%
Net Income	INR 24.6M
Net Income Growth	132.63%
Net Income Growth Q	-98.21%
Pretax Margin	13.34%
Profit Margin	10.04%
Roa5y	7.36
ROCE	15.38
Roe5y	56.37
ROIC	11.06
Roic5y	15.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	99.37
EPS Growth Q	-98.35
Revenue Growth	274.49x
Revenue Growth Q	-3.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	INR 494.8M
Cash	INR 1.8M
Current Assets	INR 378.3M
Current Liabilities	INR 89.5M
Debt	INR 39.9M
Debt EBITDA	INR 0.63
Debt Equity	INR 0.1
Equity	INR 386.3M
Interest Coverage	9.54
Liabilities	INR 108.4M
Long Term Assets	INR 116.5M
Long Term Liabilities	INR 18.9M
Net Cash	INR -38.1M
Net Cash By Market Cap	INR -5.6
Net Debt EBITDA	INR 0.6
Net Debt Equity	INR 0.1
Tangible Book Value	INR 386.3M
Tangible Book Value Per Share	INR 56.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.23
Net Working Capital	INR 309.5M
Quick ratio	3.77
Working Capital	INR 288.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	78.6
All Time High	126
All Time High Change	-36.56%
All Time High Date	2025-07-18
All Time Low	65.2
All Time Low Change	22.61%
All Time Low Date	2026-03-30
ATR	3.59
Beta1y	0.85
Ch YTD	-3.14
High	79.94
High52	126
High52 Date	2025-07-18
High52ch	-36.56%
Low	79.94
Low52	65.2
Low52 Date	2026-03-30
Low52ch	22.61%
Ma50ch	1.71%
RSI	51.86
RSI Monthly	0
RSI Weekly	39.48
Sharpe ratio	-0.95x
Sortino ratio	-1.34
Total Return	-16.68%
Tr YTD	-3.14
Tr1m	5.17%
Tr1w	1.19%
Tr3m	-1.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 62.3M
Operating Income Growth	321.3
Operating Income Growth Q	-3.55
Operating margin	25.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,180,148%
Shares Insiders	60.24%
Shares Institutions	7.95%
Shares Out	8,512,960
Shares Qo Q	0%
Shares Yo Y	16.68%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	6,500x
Bv Per Share	56.82
Ch1m	5.17
Ch1w	1.19
Ch3m	-1.72
Ch6m	2.9
Change	0%
Change From Open	0
Close	79.94
Days Gap	0
Depreciation Amortization	1,251,500
Dollar Volume	79,940
Earnings Date	2026-02-13
EBIT	INR 62.3M
EBITDA	INR 63.6M
EPS	INR 3.76
F Score	3
Fiscal Year End	March
Founded	2,019
Graham Number	69.34529
Graham Upside	-13.25
Income Tax	INR 8.1M
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-09-30
Ma150	85.62
Ma150ch	-6.64%
Ma20	80.04
Ma20ch	-0.13%
Open	79.94
Ppne	13,269,000
Price Date	2026-05-08
Price EBITDA	INR 10.7
Ptbv Ratio	1.76
Relative Volume	0.15x
Revenue	244,844,000x
Tax By Revenue	3.3x
Tax Rate	24.72%
Tr6m	2.9%
Volume	1,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/544445 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns BOM/544445?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.9%

Share of float held by funds and institutions

Insider ownership

+60.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+16.7%

Negative means the company is buying back shares.

Technical

BOM/544445 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.9

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/544445

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/544445 stock rating?

bom/544445 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/544445 analysis?

The full report lives at /stocks/bom/544445/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/544445?

The latest report frames bom/544445 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/544445 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.